Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-2_06-cv-02563/USCOURTS-caed-2_06-cv-02563-0/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1441 Petition for Removal- Personal Injury

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

1

IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF CALIFORNIA

KATHIE SABATO, et al., )

) 2:06-cv-2563-GEB-KJM

Plaintiffs, )

)

v. ) ORDER

)

MERCK & COMPANY, INC.; and ) 

MCKESSON CORPORATION, )

 )

Defendants. )

)

On December 20, 2006, Plaintiffs and Defendant Merck &

Company, Inc. (“Merck”) filed a “Stipulation and Proposed Order

Staying Proceedings Pending Transfer to Vioxx MDL No. 1657"

(“Stipulation”) in which they “request that all proceedings be stayed”

since Merck has “requested . . . this action [be transferred] to the

multidistrict litigation known as In re Vioxx Products Liability

Litigation, MDL No. 1657 . . . .” (Stipulation at 1.) 

The Stipulation was not signed by all the parties named in

this action. However, since Merck “expects . . . a conditional

transfer order that includes this case [to issue] in the next few

weeks[,]” judicial economy is served by staying the proceedings. 

(Id.) Therefore, this action is stayed pending decision on whether

Case 2:06-cv-02563-GEB -KJM Document 16 Filed 12/28/06 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

2

this case will be transferred to MDL Proceeding No. 1657 in the

Eastern District of Louisiana; except Merck shall file a status report

no later than February 5, 2007, in which it explains only the status

of its effort to transfer this action to MDL-1657.

IT IS SO ORDERED.

Dated: December 28, 2006

 

GARLAND E. BURRELL, JR.

United States District Judge

Case 2:06-cv-02563-GEB -KJM Document 16 Filed 12/28/06 Page 2 of 2